|
 |
Letter to the Editor
British Journal of Cancer (2007) 96, 679-680. doi:10.1038/sj.bjc.6603604 www.bjcancer.com Published online 6 February 2007
Reply: The long-term response to imatinib treatment of CML
F Michor1
1Society of Fellows, Harvard University, Cambridge, MA 02138, USA

Correspondence to: Dr F Michor, E-mail: michor@fas.harvard.edu
|
 |
|